Umantod, Charmaine E.
HRN: 27-35-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 500MG (TAB)
06/22/2025
06/28/2025
ORAL
500mg
BID
Sp NSVD With RMLE
Checking Initial Appropriateness
06/23/2025
CEFUROXIME 1.5GM (VIAL)
06/23/2025
06/25/2025
IV
1.5gm
Q8hrx 3doses
Sp NSVD With RMLE; PROM
Checking Initial Appropriateness